Results 61 to 70 of about 21,997 (171)

Breast Angiosarcoma: 15‐Years Experience

ANZ Journal of Surgery, Volume 96, Issue 7-8, Page 2063-2071, July-August 2026.
ABSTRACT Background Breast angiosarcoma is a rare, aggressive malignancy that can be primary (PAS) or secondary (SAS). This study evaluates the management and outcomes of breast angiosarcoma in a single‐center breast/surgical oncology unit. Methods A retrospective review was conducted on patients with histologically confirmed PAS or SAS who underwent ...
Gaik Si Quah, Christopher Pyke, Christopher Allan   +2 more
wiley   +1 more source

A Single Centre Feasibility Study of Vacuum Assisted Breast Biopsy Excision as a Non‐Surgical Alternative for Selected Women With Borderline Breast Lesions

ANZ Journal of Surgery, Volume 96, Issue 7-8, Page 2081-2092, July-August 2026.
In a feasibility study at an Australian teaching hospital, women showed a clear preference for VAB Ex over surgical breast biopsy. The clinical outcomes confirm the safety and effectiveness of this approach. Overall, 90% of women had benign VAB Ex findings and did not require SBB, creating capacity in the healthcare system.
Gelareh Farshid, Suzanna Saloniklis, Kohei Funahashi, Amardeep Sidhu, Janne Bingham, Leong Tiong, Robert Whitfield, Melissa Bochner   +7 more
wiley   +1 more source

Integration of Raman Spectroscopy and Metabolomics for Early Breast Cancer Detection and Classification

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Breast cancer, now the fourth leading cause of cancer‐related mortality worldwide, necessitates early detection for improved clinical outcomes. Conventional histopathology, though widely used, is invasive and subjective, limiting its utility in early‐stage diagnosis.
Xue Li, He Ren, Yuhan Deng, Yang Li, Fangjie Hu   +4 more
wiley   +1 more source

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Concomitant medications (CMs) influence outcomes in patients receiving immune checkpoint inhibitors (ICIs), but their impact in sarcoma remains undefined. We assessed the association between CM use and ICI outcomes in patients with advanced or metastatic sarcoma. Methods This pooled analysis included patients from seven investigator‐
Adel Shahnam, Kristen DiConza, Simran Jasnani, Rhoena Desir‐Camille, Evan Rosenbaum, Olayode Babatunde, Ciara M. Kelly, Lauren B. Banks, Viswatej Avutu, Ping Chi, Sujana Movva, Mark A. Dickson, Mrinal M. Gounder, Mary L. Keohan, Robert G. Maki, William D. Tap, Sandra P. D'Angelo   +16 more
wiley   +1 more source

The treatment process of a giant phyllodes tumor of the breast: a case report and review of the literature

Frontiers in Oncology
Giant phyllodes tumors are rare fibroepithelial tumors that are usually larger than 10 cm in diameter, have rapid tumor growth, and are easily recurrent.
Yujun Tong, Siyu Liu, Lijuan Zhao, Zhen Zhang, Haiyan Hu, Yu Jing, Tiantian Liang   +6 more
doaj   +1 more source

Beyond the Triple‐Negative Label: A Case Report on Metaplastic Breast Carcinoma

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Metaplastic breast carcinoma (MpBC) is a rare, aggressive breast malignancy with poorer prognosis than conventional subtypes. Predominant hematogenous spread, frequent triple‐negative phenotype, chemoresistance, rarity, and poorly defined treatment protocols render MpBC a significant diagnostic and therapeutic challenge for oncologists in ...
Samana Oli, Ayush Sapkota, Sajjad Ahmed Khan, Asmita Rayamajhi, Dhiraj Gupta, Vivek Ghosh, Diksha Karki, Rikesh Acharya, Prajina Shrestha   +8 more
wiley   +1 more source

Bone metastasis from malignant phyllodes of the breast [PDF]

, 2019
Cystosarcoma phyllodes was described first in 1838 and originally was considered to be a benign tumor. It was not until 1931 that metastasis from a cystosarcoma phyllodes was reported.
Dau, Daniel Oktavianus, Sudarsa, I. Wayan   +1 more
core   +1 more source

Giant phyllodes tumor of the breast: a clinical observation [PDF]

, 2018
CSF “Galaxia”, IMSP IO a RM, Conferința Științifică „Centrul Medical «Galaxia» la 20 de ani”Se prezinta caz de observare clinica si tratament a tumorii gigante filoide (TF). Tumorile phyllodes sunt leziuni fibroepiteliale rare formate din tesut epitelial
Jitaru, Natalia, Botnariuc, Natalia
core   +1 more source

KARAKTERISTIK PASIEN TUMOR PHYLLODES PAYUDARA DI RSUP SANGLAH PADA PERIODE TAHUN 2014–2018

, 2019
Tumor phyllodes adalah tumor bifasik yang memiliki karakteristik adanya dua lapis komponen sel epitel yang tersusun di dalam celah celah yang dikelilingi oleh komponen mesenkim hiperseluler yang tumbuh berlebihan yang selanjutnya akan membentuk struktur ...
Komang Chandra Surya Dika, Herman Saputra, Ni Putu Sriwidyani   +2 more
core   +1 more source

Clinical presentation and radiologic imaging findings of phyllodes tumors: benign and borderline/malignant phyllodes tumors [version 2; peer review: 2 approved]

F1000Research
Background Phyllodes tumor is a rare fibroepithelial neoplasm of the breast, which is classified histologically as benign, borderline, or malignant. Accurate preoperative diagnosis allows the correct surgical planning and reoperation avoidance. Objective
Amolchaya Kwankua, Kanitta Rodjanakonkiat, Wanrudee Lohitvisate   +2 more
doaj   +1 more source